A new study identifies biliverdin reductase A (BVRA) as a crucial enzyme defending neurons from oxidative stress, acting ...

BETHESDA, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of ...

University of Missouri researchers received a $2.74 million grant from the National Institutes of Health to combat arterial stiffening, which contributes to cardiovascular disease.

Protalix announces positive 12-month interim data from BRIDGE phase III study of pegunigalsidase alfa to treat fabry disease: Carmiel, Israel Friday, October 18, 2019, 18:00 Hrs [ ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance ...

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

Anyone who has experienced chronic pain knows how debilitating it can be. Just ask Daniele Piomelli, Ph.D., who has dealt ...

Scientists discover a byproduct of sucralose that can damage DNA, raising new questions about the safety of artificial ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients ...

Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...